GLOBAL BLOOD THERAPEUTICS IN (GBT)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$68
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $68 | 1 | 0.00% | 19q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $68 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 2 | $110 | 622 | 0 | 0 | 1 | 0.0% |
| Q3 2022 | 248 | $5.0B | 70,175,042 | 119 | 53 | 55 | 4.6% |
| Q2 2022 | 196 | $2.3B | 71,711,279 | 29 | 76 | 59 | 1.3% |
| Q1 2022 | 203 | $2.5B | 70,625,674 | 30 | 75 | 59 | 1.1% |
| Q4 2021 | 208 | $2.0B | 69,034,680 | 43 | 60 | 60 | 1.3% |
| Q3 2021 | 186 | $1.6B | 60,684,159 | 24 | 71 | 49 | 3.3% |
| Q2 2021 | 196 | $2.5B | 69,296,288 | 20 | 77 | 57 | 3.0% |
| Q1 2021 | 213 | $2.7B | 66,479,723 | 23 | 58 | 97 | 1.6% |
| Q4 2020 | 227 | $2.9B | 64,499,590 | 45 | 82 | 59 | 4.0% |
| Q3 2020 | 230 | $3.6B | 64,194,473 | 25 | 88 | 75 | 1.6% |
| Q2 2020 | 255 | $4.2B | 64,829,704 | 56 | 75 | 78 | 2.4% |
| Q1 2020 | 223 | $3.4B | 65,128,463 | 33 | 76 | 73 | 2.0% |
| Q4 2019 | 238 | $5.0B | 60,356,684 | 49 | 74 | 62 | 4.7% |
| Q3 2019 | 212 | $3.0B | 60,505,216 | 27 | 85 | 51 | 3.0% |
| Q2 2019 | 226 | $3.4B | 59,917,097 | 48 | 90 | 47 | 6.0% |
| Q1 2019 | 205 | $3.2B | 58,037,618 | 27 | 61 | 73 | 3.6% |
| Q4 2018 | 195 | $2.5B | 57,503,225 | 5 | 2 | 4 | 4.1% |